Pictet Asset Management
PTCT icon

Pictet Asset Management’s PTC Therapeutics PTCT Stock Holding History

Pictet Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.1M Buy
1,183,720
+204,763
+21% +$14.5M 0.08% 239
2025
Q4 		$74.8M Sell
978,957
-429,017
-30% -$31.2M 0.07% 259
2025
Q3 		$86.2M Buy
1,407,974
+366,543
+35% +$19.1M 0.08% 240
2025
Q2 		$51.1M Sell
1,041,431
-1,027
-0.1% -$48.8K 0.05% 311
2025
Q1 		$54M Buy
1,042,458
+306,070
+42% +$15.3M 0.06% 291
2024
Q4 		$33.2M Buy
736,388
+381,319
+107% +$16.3M 0.04% 379
2024
Q3 		$13.3M Sell
355,069
-14,921
-4% -$500K 0.01% 581
2024
Q2 		$11.3M Sell
369,990
-456,086
-55% -$14.8M 0.01% 604
2024
Q1 		$24.2M Sell
826,076
-40,484
-5% -$1.13M 0.03% 455
2023
Q4 		$23.9M Buy
866,560
+62,202
+8% +$1.42M 0.03% 441
2023
Q3 		$18M Buy
+804,358
New +$29.9M 0.02% 482

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Pictet Asset Management's PTCT Position: Q1 2026 in Review

Pictet Asset Management increased its PTC Therapeutics (PTCT) stake by 21% in Q1 2026, buying an estimated $14.5M and bringing the position to 1,183,720 shares worth $80.1M. The position accounts for 0.08% of the portfolio, ranked #239.

Pictet Asset Management first reported a position in PTCT in Q3 2023 and has held it in 11 quarters since. The position peaked at $86.2M in Q3 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Pictet Asset Management held 1,183,720 shares of PTC Therapeutics worth $80.1M as of Q1 2026.
  • Pictet Asset Management bought 204,763 PTC Therapeutics shares in Q1 2026, an estimated $14.5M.
  • PTC Therapeutics made up 0.08% of Pictet Asset Management's portfolio in Q1 2026, its #239 holding.
  • Pictet Asset Management first reported a position in PTC Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's PTC Therapeutics position peaked at $86.2M in Q3 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.